Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

December 31, 2009

Conditions
ImmunosuppressionHepatocellular CarcinomaLiver TransplantationPost-operative Complications
Interventions
DRUG

solu medrol

total dose 20mg/kg, including first dose 10mg/kg, rest of drug given within one weeks after liver transplantation

DRUG

a steroid-free immunosuppression protocol

receive immunosuppression with Basiliximab(20mg/day,twice following transplantation) and tacrolimus(0.06/kg/d,twice a day) without steroids.

Trial Locations (1)

200080

Shanghai First People's Hospital, Shanghai

All Listed Sponsors
collaborator

First Affiliated Hospital of Fujian Medical University

OTHER

collaborator

Nanchang University

OTHER

collaborator

Zhejiang University

OTHER

collaborator

Shanghai Changzheng Hospital

OTHER

lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01137084 - Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids | Biotech Hunter | Biotech Hunter